Literature DB >> 2583100

Intermolecular transphosphorylation between insulin receptors and EGF-insulin receptor chimerae.

R Ballotti1, R Lammers, J C Scimeca, T Dull, J Schlessinger, A Ullrich, E Van Obberghen.   

Abstract

The insulin receptor, a glycoprotein consisting of two extracellular alpha- and two transmembrane beta-subunits, is thought to mediate hormone action by means of its tyrosine-specific protein kinase activity. To explore the mechanism of insulin receptor phosphorylation we have used NIH3T3 cells transfected with two receptor constructs: one encoding a chimeric receptor composed of the extracellular domain of the human EGF receptor and the cytosolic domain of the human insulin receptor beta-subunit, and a second construct encoding a kinase-defiecient human insulin receptor. Stimulation of these cells with EGF induced tyrosine autophosphorylation of the EGF-insulin receptor chimera (150 kd) and tyrosine phosphorylation of the beta-subunit of the kinase-deficient insulin receptor (95 kd). The phosphopeptides of the autophosphorylated cytoplasmic domain of the EGF-insulin receptor chimera were comparable to those of the transphosphorylated beta-subunit of the kinase-deficient insulin receptor and of the wild-type human insulin receptor. When immunoaffinity purified EGF-insulin receptor hybrids and kinase-deficient insulin receptors were used in a cell lysate phosphorylation assay, it was found that addition of EGF produced 32P-labeling of both receptor species. We conclude that EGF acting directly through the EGF-insulin receptor chimera causes transphosphorylation of the kinase-deficient insulin receptor. These data support the notion that autophosphorylation of the insulin receptor may proceed by an intermolecular mechanism.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2583100      PMCID: PMC401464          DOI: 10.1002/j.1460-2075.1989.tb08491.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  31 in total

1.  Identification of a cellular 110 000-Da protein substrate for the insulin-receptor kinase.

Authors:  J L Sadoul; J F Peyron; R Ballotti; A Debant; M Fehlmann; E Van Obberghen
Journal:  Biochem J       Date:  1985-05-01       Impact factor: 3.857

Review 2.  Protein-tyrosine kinases.

Authors:  T Hunter; J A Cooper
Journal:  Annu Rev Biochem       Date:  1985       Impact factor: 23.643

3.  Antiphosphotyrosine antibodies modulate insulin receptor kinase activity and insulin action.

Authors:  R Ballotti; J C Scimeca; A Kowalski; E Van Obberghen
Journal:  Cell Signal       Date:  1989       Impact factor: 4.315

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  src kinase catalyzes the phosphorylation and activation of the insulin receptor kinase.

Authors:  K T Yu; D K Werth; I H Pastan; M P Czech
Journal:  J Biol Chem       Date:  1985-05-10       Impact factor: 5.157

6.  Tyrosine phosphorylation of the insulin receptor beta subunit activates the receptor-associated tyrosine kinase activity.

Authors:  K T Yu; M P Czech
Journal:  J Biol Chem       Date:  1984-04-25       Impact factor: 5.157

7.  The insulin receptor protein kinase. Physicochemical requirements for activity.

Authors:  M A Shia; J B Rubin; P F Pilch
Journal:  J Biol Chem       Date:  1983-12-10       Impact factor: 5.157

8.  Insulin rapidly stimulates tyrosine phosphorylation of a Mr-185,000 protein in intact cells.

Authors:  M F White; R Maron; C R Kahn
Journal:  Nature       Date:  1985 Nov 14-20       Impact factor: 49.962

9.  An endogenous substrate for the insulin receptor-associated tyrosine kinase.

Authors:  R W Rees-Jones; S I Taylor
Journal:  J Biol Chem       Date:  1985-04-10       Impact factor: 5.157

10.  Insulin receptor is an insulin-dependent tyrosine protein kinase: copurification of insulin-binding activity and protein kinase activity to homogeneity from human placenta.

Authors:  L Petruzzelli; R Herrera; O M Rosen
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

View more
  11 in total

1.  Intermolecular complementation between two defective mutant signal-transducing receptors of Escherichia coli.

Authors:  Y Yang; M Inouye
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

Review 2.  Signalling through the insulin receptor and the insulin-like growth factor-I receptor.

Authors:  E Van Obberghen
Journal:  Diabetologia       Date:  1994-09       Impact factor: 10.122

3.  Mechanism of kinase activation in the receptor for colony-stimulating factor 1.

Authors:  A W Lee; A W Nienhuis
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

4.  Insulin receptor is phosphorylated in response to treatment of HepG2 cells with insulin-like growth factor I.

Authors:  V Duronio
Journal:  Biochem J       Date:  1990-08-15       Impact factor: 3.857

5.  Lipid-induced insulin resistance in cultured hepatoma cells is associated with a decreased insulin receptor tyrosine kinase activity.

Authors:  P Hubert; C Bruneau-Wack; G Cremel; Y Le Marchand-Brustel; C Staedel
Journal:  Cell Regul       Date:  1991-01

6.  Changes in insulin-receptor tyrosine, serine and threonine phosphorylation as a result of substitution of tyrosine-1162 with phenylalanine.

Authors:  J M Tavaré; M Dickens
Journal:  Biochem J       Date:  1991-02-15       Impact factor: 3.857

7.  Cross talk among tyrosine kinase receptors in PC12 cells: desensitization of mitogenic epidermal growth factor receptors by the neurotrophic factors, nerve growth factor and basic fibroblast growth factor.

Authors:  I Mothe; R Ballotti; S Tartare; A Kowalski-Chauvel; E Van Obberghen
Journal:  Mol Biol Cell       Date:  1993-07       Impact factor: 4.138

8.  Mechanism of activation and inhibition of the HER4/ErbB4 kinase.

Authors:  Chen Qiu; Mary K Tarrant; Sung Hee Choi; Aruna Sathyamurthy; Ron Bose; Sudeep Banjade; Ashutosh Pal; William G Bornmann; Mark A Lemmon; Philip A Cole; Daniel J Leahy
Journal:  Structure       Date:  2008-03       Impact factor: 5.006

9.  Modulating effects of the extracellular sequence of the human insulinlike growth factor I receptor on its transforming and tumorigenic potential.

Authors:  D Liu; W J Rutter; L H Wang
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

10.  Tyrosine 785 is a major determinant of Trk--substrate interaction.

Authors:  A Obermeier; H Halfter; K H Wiesmüller; G Jung; J Schlessinger; A Ullrich
Journal:  EMBO J       Date:  1993-03       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.